Diaphorina citri psyllid: psy4627

Local Sequence Feature Prediction

Prediction and MethodResult
Residue Number Marker
Protein Sequence ?
Secondary Structure (Consensus) ?
Disordered Region (Consensus) ?
Transmembrane Helix (Consensus) ?
Signal Peptide (Consensus) ?
Coiled Coil (COILS) ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270
MSDVDHSPYTEVDENKSETIYRSENMDMYGVKNENPEISVNVEKDIPEDNLDHNLNSKNLLILEQMKSETAHPYLTDYFYTEVDQNKSENIYRSENLDMYGTLVKTEKPEEENYYMDEGDIMNNKRRKRSISSSSKSSSGDMKIRRKYPQTYGELHSQRILANVRERQRTQSLNEAFTSLRKLIPALPSDKLSKIQTLKLASRYIHFLCEILHGSEDGDGNNTEIVDQDRELFNGISPGGPNFESNNSNMKLTINNYNMAHEKLSYAFSV
ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHccccccccccccccccHHHccccccccccccccccccccccccccccccccccccccc
******S***************************************************NLLILEQMKSETAHPYLTDYFYT***********************************************************************************RERQRTQSLNEAFTSLRKLIPALPSDKLSKIQTLKLASRYIHFLCEILHG****************************************************AFS*
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MSDVDHSPYTEVDENKSETIYRSENMDMYGVKNENPEISVNVEKDIPEDNLDHNLNSKNLLILEQMKSETAHPYLTDYFYTEVDQNKSENIYRSENLDMYGTLVKTEKPEEENYYMDEGDIMNNKRRKRSISSSSKSSSGDMKIRRKYPQTYGELHSQRILANVRERQRTQSLNEAFTSLRKLIPALPSDKLSKIQTLKLASRYIHFLCEILHGSEDGDGNNTEIVDQDRELFNGISPGGPNFESNNSNMKLTINNYNMAHEKLSYAFSV

Function Prediction

Annotation transfered from Closely Related SWISS-PROT Entries ?

Annotation ?Function Description ?Confidence Level ?Reference Protein ?
Twist-related protein 1 Acts as a transcriptional regulator. Inhibits myogenesis by sequestrating E proteins, inhibiting trans-activation by MEF2, and inhibiting DNA-binding by MYOD1 through physical interaction. This interaction probably involves the basic domains of both proteins. Also represses expression of proinflammatory cytokines such as TNFA and IL1B. Regulates cranial suture patterning and fusion. Activates transcription as a heterodimer with E proteins. Regulates gene expression differentially, depending on dimer composition. Homodimers induce expression of FGFR2 and POSTN while heterodimers repress FGFR2 and POSTN expression and induce THBS1 expression. Heterodimerization is also required for osteoblast differentiation.confidentQ15672
Twist-related protein 1 Acts as a transcriptional regulator. Inhibits myogenesis by sequestrating E proteins, inhibiting trans-activation by MEF2, and inhibiting DNA-binding by MYOD1 through physical interaction. This interaction probably involves the basic domains of both proteins. Also represses expression of proinflammatory cytokines such as TNFA and IL1B. Regulates cranial suture patterning and fusion. Activates transcription as a heterodimer with E proteins. Regulates gene expression differentially, depending on dimer composition. Homodimers induce expression of FGFR2 and POSTN while heterodimers repress FGFR2 and POSTN expression and induce THBS1 expression. Heterodimerization is also required for osteoblast differentiation.confidentP26687

Prediction of Gene Ontology Terms ?

GO Term ?Description ?Confidence Level ?Parent GO Terms ?
GO:0003253 [BP]cardiac neural crest cell migration involved in outflow tract morphogenesisprobableGO:0061307, GO:0048762, GO:0030154, GO:0061308, GO:0061309, GO:0006928, GO:0072359, GO:0072358, GO:0001667, GO:0009653, GO:0007275, GO:0044699, GO:0003151, GO:0014033, GO:0014031, GO:0048864, GO:0048869, GO:0048513, GO:0016477, GO:0032502, GO:0014032, GO:0009887, GO:0032501, GO:0035051, GO:0009987, GO:0060973, GO:0009888, GO:0048468, GO:0003007, GO:0048863, GO:0008150, GO:0001755, GO:0060485, GO:0051179, GO:0040011, GO:0007507, GO:0044707, GO:0048870, GO:0048856, GO:0044763, GO:0051674, GO:0044767, GO:0048731
GO:0032760 [BP]positive regulation of tumor necrosis factor productionprobableGO:0001817, GO:0051240, GO:0032680, GO:0065007, GO:0051239, GO:0048518, GO:0008150, GO:0050789, GO:0001819
GO:0003203 [BP]endocardial cushion morphogenesisprobableGO:0032502, GO:0007507, GO:0009887, GO:0032501, GO:0044707, GO:0048513, GO:0048856, GO:0009888, GO:0072359, GO:0048731, GO:0003007, GO:0003197, GO:0072358, GO:0044767, GO:0008150, GO:0048729, GO:0060485, GO:0072132, GO:0009653, GO:0007275, GO:0044699
GO:0048701 [BP]embryonic cranial skeleton morphogenesisprobableGO:0048598, GO:0048562, GO:0048568, GO:0009790, GO:0048706, GO:0009653, GO:0007275, GO:0044699, GO:0048513, GO:0043009, GO:0048705, GO:0048704, GO:0009887, GO:0032501, GO:0044767, GO:0008150, GO:0044707, GO:0001501, GO:0048856, GO:0032502, GO:0009792, GO:0048731
GO:2000276 [BP]negative regulation of oxidative phosphorylation uncoupler activityprobableGO:0032410, GO:2000275, GO:0051051, GO:0008150, GO:0022898, GO:0050794, GO:0050789, GO:0032409, GO:0065007, GO:0051049, GO:0048519, GO:0044092, GO:0010155, GO:0034762, GO:0032879, GO:0065009, GO:0043269
GO:2000780 [BP]negative regulation of double-strand break repairprobableGO:0009892, GO:0080090, GO:0019222, GO:0048585, GO:0031324, GO:0048583, GO:0006282, GO:0050789, GO:0051052, GO:0010605, GO:0019219, GO:0065007, GO:0048519, GO:0051053, GO:0045934, GO:0060255, GO:0031323, GO:0050794, GO:0008150, GO:0051171, GO:0051172, GO:2001021, GO:2001020, GO:0080134, GO:0080135, GO:2000779, GO:0045738, GO:0048523
GO:0050679 [BP]positive regulation of epithelial cell proliferationprobableGO:0008284, GO:0042127, GO:0050678, GO:0050794, GO:0065007, GO:0048518, GO:0008150, GO:0050789, GO:0048522
GO:0032000 [BP]positive regulation of fatty acid beta-oxidationprobableGO:0009896, GO:0045923, GO:0009894, GO:0009893, GO:0031329, GO:0031325, GO:0031323, GO:0046321, GO:0046320, GO:0050789, GO:0080090, GO:0019222, GO:0010565, GO:0045834, GO:0048518, GO:0065007, GO:0019217, GO:0019216, GO:0031331, GO:0050794, GO:0008150, GO:0031998, GO:0050994, GO:0050996, GO:0048522
GO:0000122 [BP]negative regulation of transcription from RNA polymerase II promoterprobableGO:0009892, GO:0080090, GO:0009890, GO:0031327, GO:0031326, GO:0031324, GO:0031323, GO:0010629, GO:0050789, GO:0010605, GO:0019222, GO:2000112, GO:2000113, GO:0060255, GO:0006357, GO:0065007, GO:0048519, GO:0010468, GO:0045934, GO:0019219, GO:0009889, GO:0050794, GO:0045892, GO:0051171, GO:0051172, GO:2001141, GO:0051253, GO:0051252, GO:0006355, GO:0010556, GO:0008150, GO:0010558, GO:0048523
GO:0060021 [BP]palate developmentprobableGO:0032502, GO:0048856, GO:0008150
GO:0043066 [BP]negative regulation of apoptotic processprobableGO:0043069, GO:0050794, GO:0008150, GO:0043067, GO:0065007, GO:0060548, GO:0048519, GO:0010941, GO:0042981, GO:0050789, GO:0048523
GO:0045668 [BP]negative regulation of osteoblast differentiationprobableGO:0051093, GO:0050793, GO:0045595, GO:0050794, GO:0008150, GO:0045596, GO:0045667, GO:0065007, GO:0051239, GO:0048519, GO:0030278, GO:0050789, GO:0048523
GO:2000802 [BP]positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formationprobableGO:0022604, GO:2000736, GO:0022603, GO:0051128, GO:0050789, GO:2000826, GO:0060284, GO:0010769, GO:0065007, GO:0010720, GO:0048518, GO:0051130, GO:0050793, GO:0050794, GO:0045597, GO:0045595, GO:0008150, GO:0051239, GO:2000800, GO:0010718, GO:0010717, GO:0051094, GO:2000026, GO:2000027, GO:0010770, GO:0048522
GO:0014029 [BP]neural crest formationprobableGO:0048863, GO:0030154, GO:0048468, GO:0009790, GO:0009792, GO:0009653, GO:0007275, GO:0044699, GO:0014031, GO:0048864, GO:0000902, GO:0048869, GO:0016043, GO:0032989, GO:0008150, GO:0048513, GO:0071840, GO:0043009, GO:0032502, GO:0048762, GO:0032501, GO:0009987, GO:0009888, GO:0044767, GO:0000904, GO:0044763, GO:0060485, GO:0044707, GO:0048856, GO:0001837, GO:0048731
GO:0001764 [BP]neuron migrationprobableGO:0040011, GO:0032502, GO:0048699, GO:0048856, GO:0044707, GO:0007399, GO:0048870, GO:0009987, GO:0048869, GO:0032501, GO:0030154, GO:0006928, GO:0008150, GO:0051674, GO:0044763, GO:0007275, GO:0048731, GO:0022008, GO:0016477, GO:0051179, GO:0044699
GO:0070888 [MF]E-box bindingprobableGO:0044212, GO:0097159, GO:0000975, GO:0001067, GO:0003674, GO:0005488, GO:0003676, GO:0003677, GO:1901363
GO:0006366 [BP]transcription from RNA polymerase II promoterprobableGO:0032774, GO:0090304, GO:0044249, GO:0034641, GO:0006807, GO:0034645, GO:1901362, GO:1901360, GO:1901576, GO:0044260, GO:0071704, GO:0010467, GO:0018130, GO:0006139, GO:0009987, GO:0006725, GO:0009058, GO:0009059, GO:0008150, GO:0008152, GO:0034654, GO:0046483, GO:0016070, GO:0044238, GO:0044271, GO:0044237, GO:0043170, GO:0006351, GO:0019438
GO:0061029 [BP]eyelid development in camera-type eyeprobableGO:0032502, GO:0032501, GO:0044707, GO:0007423, GO:0048856, GO:0044767, GO:0048513, GO:0001654, GO:0048731, GO:0008150, GO:0043010, GO:0007275, GO:0044699
GO:0009953 [BP]dorsal/ventral pattern formationprobableGO:0032502, GO:0007389, GO:0032501, GO:0044707, GO:0008150, GO:0003002, GO:0007275, GO:0044699
GO:2000147 [BP]positive regulation of cell motilityprobableGO:0051272, GO:0040012, GO:0040017, GO:0050794, GO:0008150, GO:0051270, GO:2000145, GO:0048518, GO:0065007, GO:0032879, GO:0050789, GO:0048522
GO:0046982 [MF]protein heterodimerization activityprobableGO:0046983, GO:0003674, GO:0005488, GO:0005515
GO:0071456 [BP]cellular response to hypoxiaprobableGO:0009628, GO:0051716, GO:0070887, GO:0036293, GO:0050896, GO:0009987, GO:0071453, GO:0036294, GO:0008150, GO:0006950, GO:0044763, GO:0033554, GO:0042221, GO:0001666, GO:0044699, GO:0070482
GO:0014067 [BP]negative regulation of phosphatidylinositol 3-kinase cascadeprobableGO:0010646, GO:0009968, GO:0009966, GO:0048585, GO:0048583, GO:0050794, GO:0008150, GO:0023057, GO:0065007, GO:0010648, GO:0023051, GO:0048519, GO:0014066, GO:0050789, GO:0048523
GO:0001649 [BP]osteoblast differentiationprobableGO:0032502, GO:0032501, GO:0044707, GO:0048869, GO:0030154, GO:0001503, GO:0044763, GO:0008150, GO:0009987, GO:0044699
GO:0035116 [BP]embryonic hindlimb morphogenesisprobableGO:0048598, GO:0032502, GO:0044699, GO:0035108, GO:0044707, GO:0030326, GO:0060173, GO:0035107, GO:0044767, GO:0009790, GO:0032501, GO:0008150, GO:0035137, GO:0035113, GO:0009653, GO:0007275, GO:0048736, GO:0048856
GO:0030500 [BP]regulation of bone mineralizationprobableGO:0050793, GO:0070167, GO:0008150, GO:2000026, GO:0051239, GO:0065007, GO:0030278, GO:0050789
GO:2000679 [BP]positive regulation of transcription regulatory region DNA bindingprobableGO:0051099, GO:0051098, GO:0051101, GO:2000677, GO:0065007, GO:0044093, GO:0043388, GO:0008150, GO:0065009
GO:0032720 [BP]negative regulation of tumor necrosis factor productionprobableGO:0001817, GO:0051241, GO:0008150, GO:0032680, GO:0065007, GO:0051239, GO:0048519, GO:0050789, GO:0001818
GO:0043433 [BP]negative regulation of sequence-specific DNA binding transcription factor activityprobableGO:0009889, GO:0051090, GO:0019219, GO:0080090, GO:0019222, GO:0060255, GO:0031326, GO:0031323, GO:0044092, GO:2000112, GO:0050794, GO:0050789, GO:0006355, GO:0010556, GO:0065007, GO:0051171, GO:2001141, GO:0008150, GO:0065009, GO:0051252, GO:0010468
GO:0019904 [MF]protein domain specific bindingprobableGO:0003674, GO:0005488, GO:0005515
GO:0048642 [BP]negative regulation of skeletal muscle tissue developmentprobableGO:0051093, GO:0016202, GO:0045843, GO:1901862, GO:0050793, GO:0048635, GO:0048634, GO:0008150, GO:0065007, GO:2000026, GO:0051239, GO:0048519, GO:0048641, GO:1901861, GO:0050789
GO:0003682 [MF]chromatin bindingprobableGO:0003674, GO:0005488
GO:0003183 [BP]mitral valve morphogenesisprobableGO:0032502, GO:0007507, GO:0003170, GO:0044707, GO:0048513, GO:0032501, GO:0048856, GO:0072359, GO:0044767, GO:0003179, GO:0072358, GO:0008150, GO:0048731, GO:0009653, GO:0007275, GO:0044699, GO:0003174
GO:0003180 [BP]aortic valve morphogenesisprobableGO:0032502, GO:0007507, GO:0003170, GO:0044707, GO:0048513, GO:0032501, GO:0048856, GO:0072359, GO:0007275, GO:0044767, GO:0003179, GO:0072358, GO:0008150, GO:0048731, GO:0009653, GO:0003176, GO:0044699
GO:0060363 [BP]cranial suture morphogenesisprobableGO:0032502, GO:0048705, GO:0009887, GO:0032501, GO:0044707, GO:0048856, GO:0097094, GO:0060349, GO:0060348, GO:0044767, GO:0001501, GO:0048513, GO:0008150, GO:0048731, GO:0009653, GO:0007275, GO:0044699
GO:0005737 [CC]cytoplasmprobableGO:0044424, GO:0005575, GO:0044464, GO:0005623, GO:0005622
GO:0001701 [BP]in utero embryonic developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0009790, GO:0009792, GO:0008150, GO:0043009, GO:0007275, GO:0044699
GO:0060900 [BP]embryonic camera-type eye formationprobableGO:0048598, GO:0048562, GO:0048568, GO:0031076, GO:0009790, GO:0009653, GO:0007275, GO:0048048, GO:0048513, GO:0044699, GO:0048646, GO:0032502, GO:0009887, GO:0032501, GO:0048592, GO:0048593, GO:0048596, GO:0044767, GO:0008150, GO:0044707, GO:0007423, GO:0001654, GO:0048856, GO:0048731, GO:0043010
GO:0042803 [MF]protein homodimerization activityprobableGO:0046983, GO:0003674, GO:0005515, GO:0042802, GO:0005488
GO:0071363 [BP]cellular response to growth factor stimulusprobableGO:0051716, GO:0050896, GO:0009987, GO:0070848, GO:0008150, GO:0071310, GO:0044763, GO:0070887, GO:0042221, GO:0010033, GO:0044699
GO:2000778 [BP]positive regulation of interleukin-6 secretionprobableGO:0051046, GO:0051047, GO:0051049, GO:0051222, GO:0051223, GO:0050789, GO:0032880, GO:0050708, GO:0060341, GO:0050707, GO:0065007, GO:0048518, GO:0032675, GO:0070201, GO:0051050, GO:0050794, GO:0008150, GO:0051239, GO:0032879, GO:0050715, GO:0050714, GO:0001817, GO:0048522
GO:2000773 [BP]negative regulation of cellular senescenceprobableGO:0051093, GO:0090342, GO:0090344, GO:0050793, GO:0048585, GO:0080135, GO:0048583, GO:0050794, GO:0008150, GO:0080134, GO:0065007, GO:0048519, GO:2000772, GO:0050789, GO:0048523
GO:0001076 [MF]RNA polymerase II transcription factor binding transcription factor activityprobableGO:0003674, GO:0000989, GO:0000988
GO:0035359 [BP]negative regulation of peroxisome proliferator activated receptor signaling pathwayprobableGO:0009968, GO:0009966, GO:0048585, GO:0048583, GO:0048519, GO:0050794, GO:0008150, GO:0023057, GO:0065007, GO:0010648, GO:0023051, GO:0048523, GO:0010646, GO:0050789, GO:0035358
GO:0033128 [BP]negative regulation of histone phosphorylationprobableGO:0033044, GO:0019220, GO:0080090, GO:0019222, GO:0033043, GO:0031324, GO:0031323, GO:0051129, GO:0051128, GO:0031057, GO:0031056, GO:0009892, GO:0050789, GO:0044699, GO:0051248, GO:0010605, GO:0010563, GO:0051246, GO:0065007, GO:0031399, GO:0048519, GO:0033127, GO:0045936, GO:0060255, GO:0009987, GO:0050794, GO:0051174, GO:0032268, GO:0044763, GO:0042325, GO:0032269, GO:0042326, GO:0031400, GO:0010639, GO:0008150, GO:0001933, GO:0001932, GO:0048523, GO:2001251
GO:0071639 [BP]positive regulation of monocyte chemotactic protein-1 productionprobableGO:0032642, GO:0051240, GO:0001817, GO:0065007, GO:0051239, GO:0048518, GO:0008150, GO:0032722, GO:0050789, GO:0071637, GO:0001819
GO:0006915 [BP]apoptotic processprobableGO:0010259, GO:0009987, GO:0012501, GO:0044763, GO:0008150, GO:0007569, GO:0044699
GO:0035067 [BP]negative regulation of histone acetylationprobableGO:0033044, GO:0009892, GO:0035065, GO:0019222, GO:0033043, GO:0031324, GO:0031323, GO:0051129, GO:0051128, GO:0031057, GO:0031056, GO:0050789, GO:0044699, GO:0080090, GO:0051248, GO:0010605, GO:0051246, GO:0065007, GO:0031399, GO:0048519, GO:0060255, GO:0009987, GO:0050794, GO:1901984, GO:0044763, GO:1901983, GO:0032269, GO:0032268, GO:0031400, GO:0010639, GO:2000756, GO:2000757, GO:0008150, GO:0048523, GO:2001251
GO:0043425 [MF]bHLH transcription factor bindingprobableGO:0008134, GO:0003674, GO:0005488, GO:0005515
GO:0001843 [BP]neural tube closureprobableGO:0032502, GO:0016331, GO:0035148, GO:0009790, GO:0072175, GO:0009792, GO:0021915, GO:0009653, GO:0007275, GO:0044699, GO:0002009, GO:0048729, GO:0001841, GO:0060562, GO:0043009, GO:0048646, GO:0048598, GO:0032501, GO:0035239, GO:0060429, GO:0009888, GO:0060606, GO:0008150, GO:0035295, GO:0001838, GO:0014020, GO:0044707, GO:0007399, GO:0048856, GO:0044767, GO:0048731
GO:0000981 [MF]sequence-specific DNA binding RNA polymerase II transcription factor activityprobableGO:0003700, GO:0003674, GO:0001071
GO:0043392 [BP]negative regulation of DNA bindingprobableGO:0051098, GO:0051101, GO:0051100, GO:0065007, GO:0044092, GO:0008150, GO:0065009
GO:0035115 [BP]embryonic forelimb morphogenesisprobableGO:0048598, GO:0032502, GO:0035108, GO:0044707, GO:0030326, GO:0060173, GO:0035107, GO:0044767, GO:0009790, GO:0032501, GO:0035136, GO:0044699, GO:0035113, GO:0008150, GO:0009653, GO:0007275, GO:0048736, GO:0048856
GO:0005634 [CC]nucleusprobableGO:0043231, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0043229, GO:0044424, GO:0043227, GO:0043226
GO:0042733 [BP]embryonic digit morphogenesisprobableGO:0048598, GO:0032502, GO:0035108, GO:0044707, GO:0030326, GO:0060173, GO:0035107, GO:0044767, GO:0009790, GO:0032501, GO:0008150, GO:0048736, GO:0035113, GO:0009653, GO:0007275, GO:0044699, GO:0048856
GO:0045944 [BP]positive regulation of transcription from RNA polymerase II promoterprobableGO:0009893, GO:0019222, GO:0031328, GO:0031326, GO:0031325, GO:2001141, GO:0031323, GO:0010628, GO:0050789, GO:0080090, GO:0010604, GO:0051171, GO:0009891, GO:2000112, GO:0019219, GO:0010556, GO:0065007, GO:0048518, GO:0010468, GO:0045935, GO:0060255, GO:0009889, GO:0050794, GO:0008150, GO:0045893, GO:0051173, GO:0051252, GO:0051254, GO:0006355, GO:0010557, GO:0006357, GO:0048522
GO:2000793 [BP]cell proliferation involved in heart valve developmentprobableGO:0032502, GO:0007507, GO:0032501, GO:0044707, GO:0008283, GO:0072358, GO:0048856, GO:0044767, GO:0072359, GO:0048513, GO:0008150, GO:0048731, GO:0003170, GO:0007275, GO:0044699
GO:0043518 [BP]negative regulation of DNA damage response, signal transduction by p53 class mediatorprobableGO:0010646, GO:0009968, GO:0023057, GO:0009966, GO:0050789, GO:0048585, GO:0080135, GO:0048583, GO:0050794, GO:0023051, GO:2001021, GO:0065007, GO:0048519, GO:0008150, GO:1901796, GO:1901797, GO:2001020, GO:0043516, GO:0080134, GO:0048523, GO:0010648
GO:0042476 [BP]odontogenesisprobableGO:0032502, GO:0009887, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0048513, GO:0008150, GO:0048731, GO:0009653, GO:0007275, GO:0044699

Prediction of Enzyme Commission Number ?

No EC number assigned to the protein, probably not an enzyme!

Spatial Structural Prediction

Structural Models Based on Templates

Template: 2QL2, chain B
Confidence level:very confident
Coverage over the Query: 158-214
View the alignment between query and template
View the model in PyMOL